Siolta Therapeutics Is A Clinical Stage Biotechnology Company Based In San Carloscaliforniafounded In 2016The Company Focuses On Developing Live Biotherapeutic Products That Target The Core Drivers Of Diseases Related To The Human Microbiomesiolta Therapeutics Aims To Address Significant Unmet Medical Needsparticularly In Areas Such As Atopic Diseaseswomen S Healthand Rare Pediatric Conditions The Company Specializes In Creating Therapeutic Microbial Consortia To Prevent And Treat Inflammatory Diseasestheir Precision Symbiotics Platform Translates Microbiome Science Into Innovative Therapeuticsoffering New Approaches For Conditions Where Traditional Treatments May Be Limitedsiolta Therapeutics Is Dedicated To Developing Products That Interact With The Body S Microbiota To Help Regulate The Immune System And Prevent Diseases
